A Ludwig Cancer Research study has uncovered a surprising link between diet, intestinal microbes and the efficacy of cancer therapy.
Led by Ludwig Princeton’s Asael Roichman and Branch Director Joshua Rabinowitz, the study could help explain why drugs known as PI3 kinase (PI3K) inhibitors — which disrupt an abnormally activated biochemical signaling pathway that spurs cancer cell proliferation — haven’t led to consistent, durable cancer control in patients with solid tumors.
“Many cancer…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply